-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Analyzing Summit Healthcare Acquisition (SMIH) & Its Competitors
Analyzing Summit Healthcare Acquisition (SMIH) & Its Competitors
Summit Healthcare Acquisition (NASDAQ:SMIH – Get Rating) is one of 710 public companies in the "Holding & other investment offices" industry, but how does it contrast to its rivals? We will compare Summit Healthcare Acquisition to similar companies based on the strength of its institutional ownership, profitability, analyst recommendations, valuation, earnings, dividends and risk.
Profitability
This table compares Summit Healthcare Acquisition and its rivals' net margins, return on equity and return on assets.
Get Summit Healthcare Acquisition alerts:| Net Margins | Return on Equity | Return on Assets | |
| Summit Healthcare Acquisition | N/A | 46.53% | 8.78% |
| Summit Healthcare Acquisition Competitors | 11.67% | -68.35% | 2.51% |
Valuation & Earnings
This table compares Summit Healthcare Acquisition and its rivals revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Summit Healthcare Acquisition | N/A | -$550,000.00 | 12.51 |
| Summit Healthcare Acquisition Competitors | $1.72 billion | $88.36 million | 25.15 |
Insider & Institutional Ownership
64.3% of shares of all "Holding & other investment offices" companies are held by institutional investors. 17.6% of shares of all "Holding & other investment offices" companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Summit Healthcare Acquisition and its rivals, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Summit Healthcare Acquisition | 0 | 0 | 0 | 0 | N/A |
| Summit Healthcare Acquisition Competitors | 113 | 591 | 885 | 18 | 2.50 |
As a group, "Holding & other investment offices" companies have a potential upside of 65.47%. Given Summit Healthcare Acquisition's rivals higher possible upside, analysts clearly believe Summit Healthcare Acquisition has less favorable growth aspects than its rivals.
Risk & Volatility
Summit Healthcare Acquisition has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. Comparatively, Summit Healthcare Acquisition's rivals have a beta of 0.05, suggesting that their average share price is 95% less volatile than the S&P 500.
Summary
Summit Healthcare Acquisition rivals beat Summit Healthcare Acquisition on 8 of the 10 factors compared.
About Summit Healthcare Acquisition
(Get Rating)
Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.
Receive News & Ratings for Summit Healthcare Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Summit Healthcare Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
Summit Healthcare Acquisition (NASDAQ:SMIH – Get Rating) is one of 710 public companies in the "Holding & other investment offices" industry, but how does it contrast to its rivals? We will compare Summit Healthcare Acquisition to similar companies based on the strength of its institutional ownership, profitability, analyst recommendations, valuation, earnings, dividends and risk.
顶峰医疗收购(纳斯达克：SMIH-GET评级)是“控股和其他投资办公室”行业的710家上市公司之一，但它与竞争对手有何不同？我们将根据收购的机构所有权、盈利能力、分析师建议、估值、收益、股息和风险将Summit Healthcare收购与类似公司进行比较。
Profitability
盈利能力
This table compares Summit Healthcare Acquisition and its rivals' net margins, return on equity and return on assets.
此表比较了Summit Healthcare收购及其竞争对手的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Summit Healthcare Acquisition | N/A | 46.53% | 8.78% |
| Summit Healthcare Acquisition Competitors | 11.67% | -68.35% | 2.51% |
| 净利润率 | 股本回报率 | 资产回报率 | |
| Summit Healthcare收购 | 不适用 | 46.53% | 8.78% |
| Summit Healthcare收购竞争对手 | 11.67% | -68.35% | 2.51% |
Valuation & Earnings
估值与收益
This table compares Summit Healthcare Acquisition and its rivals revenue, earnings per share (EPS) and valuation.
此表比较了Summit Healthcare收购及其竞争对手的收入、每股收益(EPS)和估值。
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Summit Healthcare Acquisition | N/A | -$550,000.00 | 12.51 |
| Summit Healthcare Acquisition Competitors | $1.72 billion | $88.36 million | 25.15 |
| 总收入 | 净收入 | 市盈率 | |
| Summit Healthcare收购 | 不适用 | -$550,000.00 | 12.51 |
| Summit Healthcare收购竞争对手 | 17.2亿美元 | 8836万美元 | 25.15 |
Insider & Institutional Ownership
内部人与机构所有权
64.3% of shares of all "Holding & other investment offices" companies are held by institutional investors. 17.6% of shares of all "Holding & other investment offices" companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
所有“控股及其他投资办事处”公司64.3%的股份由机构投资者持有。所有“控股及其他投资办事处”公司17.6%的股份由内部人士持有。强大的机构持股表明，捐赠基金、大型基金管理公司和对冲基金相信，一家公司的长期表现将好于大盘。
Analyst Recommendations
分析师建议
This is a breakdown of current ratings and price targets for Summit Healthcare Acquisition and its rivals, as provided by MarketBeat.
这是由MarketBeat提供的Summit Healthcare Acquisition及其竞争对手的当前评级和目标价细分。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Summit Healthcare Acquisition | 0 | 0 | 0 | 0 | N/A |
| Summit Healthcare Acquisition Competitors | 113 | 591 | 885 | 18 | 2.50 |
| 销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
| Summit Healthcare收购 | 0 | 0 | 0 | 0 | 不适用 |
| Summit Healthcare收购竞争对手 | 113 | 591 | 885 | 18 | 2.50 |
As a group, "Holding & other investment offices" companies have a potential upside of 65.47%. Given Summit Healthcare Acquisition's rivals higher possible upside, analysts clearly believe Summit Healthcare Acquisition has less favorable growth aspects than its rivals.
作为一个整体，“控股和其他投资办公室”公司有65.47%的潜在上行空间。考虑到Summit Healthcare收购的竞争对手更有可能的上行空间，分析师显然认为Summit Healthcare收购的增长方面不如竞争对手有利。
Risk & Volatility
风险与波动性
Summit Healthcare Acquisition has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. Comparatively, Summit Healthcare Acquisition's rivals have a beta of 0.05, suggesting that their average share price is 95% less volatile than the S&P 500.
Summit Healthcare收购的贝塔系数为0.01，表明其股价的波动性比标准普尔500指数低99%。相比之下，Summit Healthcare收购的竞争对手的贝塔系数为0.05，这表明它们的平均股价波动性比标准普尔500指数低95%。
Summary
摘要
Summit Healthcare Acquisition rivals beat Summit Healthcare Acquisition on 8 of the 10 factors compared.
Summit Healthcare收购的竞争对手在比较的10个因素中有8个击败了Summit Healthcare收购。
About Summit Healthcare Acquisition
关于Summit Healthcare收购
(Get Rating)
(获取评级)
Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.
Summit Healthcare Acquisition Corp.没有重大业务。拟与一个或者多个企业或者实体进行合并、换股、资产收购、股份购买、重组或者类似的业务合并。该公司成立于2020年，总部设在香港中环。
Receive News & Ratings for Summit Healthcare Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Summit Healthcare Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
收到Summit Healthcare收购日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Summit Healthcare收购和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧